POSC66 Cost-Effectiveness of Avelumab as First-Line Maintenance Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Finland
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.471
https://www.valueinhealthjournal.com/article/S1098-3015(21)02266-X/fulltext
Title :
POSC66 Cost-Effectiveness of Avelumab as First-Line Maintenance Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Finland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02266-X&doi=10.1016/j.jval.2021.11.471
First page :
Section Title :
Open access? :
No
Section Order :
11245